PDGF regulates the actin cytoskeleton through hnRNP-K-mediated activation of the ubiquitin E3-ligase MIR

EMBO J. 2006 May 3;25(9):1871-82. doi: 10.1038/sj.emboj.7601059. Epub 2006 Apr 13.

Abstract

PDGF is a potent chemotactic mitogen and a strong inductor of fibroblast motility. In Swiss 3T3 fibroblasts, exposure to PDGF but not EGF or IGF-1 causes a rapid loss of actin stress fibers (SFs) and focal adhesions (FAs), which is followed by the development of retractile dendritic protrusions and induction of motility. The PDGF-specific actin reorganization was blocked by inhibition of Src-kinase and the 26S proteasome. PDGF induced Src-dependent association between the multifunctional transcription/translation regulator hnRNP-K and the mRNA-encoding myosin regulatory light-chain (MRLC)-interacting protein (MIR), a E(3)-ubiquitin ligase that is MRLC specific. This in turn rapidly increased MIR expression, and led to ubiquitination and proteasome-mediated degradation of MRLC. Downregulation of MIR by RNA muting prevented the reorganization of actin structures and severely reduced the migratory and wound-healing potential of PDGF-treated cells. The results show that activation of MIR and the resulting removal of diphosphorylated MRLC are essential for PDGF to instigate and maintain control over the actin-myosin-based contractile system in Swiss 3T3 fibroblasts. The PDGF induced protein destabilization through the regulation of hnRNP-K controlled ubiquitin -ligase translation identifies a novel pathway by which external stimuli can regulate phenotypic development through rapid, organelle-specific changes in the activity and stability of cytoskeletal regulators.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / metabolism
  • Actins / drug effects*
  • Actins / metabolism
  • Animals
  • Cell Movement
  • Cytoskeleton / drug effects*
  • Cytoskeleton / metabolism
  • Cytoskeleton / ultrastructure
  • Down-Regulation
  • Enzyme Activation
  • Epidermal Growth Factor / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / physiology
  • Fibroblasts / ultrastructure
  • Heterogeneous-Nuclear Ribonucleoprotein K / metabolism*
  • Insulin-Like Growth Factor I / pharmacology
  • Mice
  • Myosin Light Chains / metabolism
  • Platelet-Derived Growth Factor / pharmacology*
  • Proteasome Endopeptidase Complex
  • Proteasome Inhibitors
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology
  • Swiss 3T3 Cells
  • Ubiquitin-Protein Ligases / antagonists & inhibitors
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism*
  • src-Family Kinases / antagonists & inhibitors

Substances

  • Actins
  • Heterogeneous-Nuclear Ribonucleoprotein K
  • Myosin Light Chains
  • Platelet-Derived Growth Factor
  • Proteasome Inhibitors
  • RNA, Small Interfering
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I
  • March8 protein, mouse
  • Ubiquitin-Protein Ligases
  • src-Family Kinases
  • Proteasome Endopeptidase Complex
  • ATP dependent 26S protease